Four types of birth control made by Apotex Corp. are directly being recalled due to incorrect tablet arrangements and/or empty blister pockets.
The birth control medications affected are Drospirenone and Ethinyl Estradiol tablets with the following lot numbers:
According to the FDA, when a patient does not take a tablet due to a missing tablet or that a patient takes a placebo instead of an active tablet, loss of efficacy is possible due to variation in the dosage consumed.
To date, no case has been reported for pregnancy and adverse event to Apotex. Patients who have received impacted lots of Drospirenone and Ethinyl Estradiol tablets, USP 3MG/0.03MG or have questions regarding the recall are advised to contact their pharmacy.
Individuals should not interrupt their therapy, use a non-hormonal method of birth control, contact their health care provider for medical advice and may return the impacted packages to their pharmacist.
Consumers with questions regarding the recall can contact Apotex by calling 1-800-706-5575 or emailing UScustomerservice@Apotex.com.
Consumers are advised to contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.